FDA Raps Supplement Maker Marco Pharma For GMP Violations Surfaced During Inspection
Executive Summary
The US Food and Drug Administration directs Marco Pharma International to correct GMP compliance issues identified during a May 2019 site inspection, including quality control and recordkeeping failures, in a warning letter made public 4 February.